Saturday, October 31, 2026

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

K-Beauty Revolution: How BEMT is Transforming Sunscreen in the U.S. Market

K-beauty sunscreens gain FDA approval for bemotrizinol, enhancing UV protection, but U.S. regulations complicate exports.

North Korea’s Lazarus Group Behind $1.5 Billion Bybit Hack

North Korea's Lazarus Group hacked Bybit, stealing $1.5 billion and causing $4 billion in withdrawals, marking the largest crypto hack ever.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

EPPE: The Korean Weight Loss Drug Revolutionizing Obesity Treatment in 2026

EPPE claims to be a weight loss drug tailored specifically for Koreans.

AI-Powered K-NEXUS: Revolutionizing Cancer Care in Regional Hospitals

A plan is underway to connect cancer treatment at large hospitals with AI, improving local care and reducing healthcare disparities.

L&C Bio Successfully Raises 144.7 Billion KRW in Rights Offering: What’s Next for Re2O’s Global Expansion Strategy?

L&C Bio successfully raised funds through a rights offering, exceeding 100% subscription, to expand production and global operations.

How SkyLabs’ CART Device Achieved 65.8% Blood Pressure Control: A Game Changer for Hypertension Patients

Patients using Sky Labs' ring-shaped blood pressure monitor achieved better results in blood pressure control after six months.

SEERS Launches AI-Based Arrhythmia Screening in UAE: A Game Changer for National Health Checkups?

Sears initiates a pilot program for AI-based arrhythmia detection in the UAE's national health screening initiative.

KIR-CAR Breakthrough: A Deep Dive into Its Potential Against Ovarian and Pancreatic Cancers

HLB Innovation's US subsidiary, Verismo Therapeutics, will present preclinical results of its KIR-CAR platform for solid tumors at an international conference.

LCB02A: The Promising ADC Drug Targeting CLDN18.2 in Cancer Treatment

Rigakem Bio has initiated global clinical trials for its ADC candidate LCB02A after completing the first patient dosing.

Unlocking Japan’s Beauty Market: How the Pastelle Pro Laser Device is Revolutionizing Skin Treatments

Wontech secures approval for laser medical device Pastelle Pro in Japan, targeting the world's fourth-largest beauty treatment market.

Revolutionary HIPEC Treatment for Peritoneal Metastasis: A Breakthrough in Small Intestinal Cancer Surgery

Advanced treatment successfully removed colorectal cancer spread to the peritoneum, targeting even invisible cancer cells.

SYN-duo CC Unveiled: The Next Big Step in ADC Technology for Cancer Treatment

Qurient accelerates global commercialization of dual payload antibody-drug conjugate platform developed with Lonza.

How Osstem Pharma’s Vussen is Redefining Oral Care in the MENA Region: Insights from Beautyworld Dubai 2026

Osteom Pharma showcased premium oral care products at a global beauty expo in Dubai, targeting the Middle East and North Africa market.

How Early Diagnosis of Mild Cognitive Impairment (MCI) Can Transform Dementia Prevention in 2026

Early detection and management of dementia focus on mild cognitive impairment, aided by government policies and advanced diagnostic techniques.

How to Support At-Risk Youth: Essential Changes for South Korea’s Independence Preparation Policy

No one chooses their starting point in life; the state's role is to balance inequalities and provide support for recovery.

L&C Bio Secures UAE Import Approval for Re2O, Paving Way for Middle East Expansion

L&C Bio has secured import approval from the UAE’s Emirates Drug Establishment for its human tissue-based product Re2O, expanding its international footprint following regulatory approvals in Thailand and Peru and a supply agreement in the United States.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.